Abstract: Therapeutic chondrisome and mitoplast compositions and related methods are described.

Abstract: Therapeutic chondrisome compositions and related methods are described.

Abstract: The present disclosure provides, at least in part, methods and compositions for producing fusosomes. In some embodiments, a producer cell for producing fusosomes comprises an exogenous or overexpresed cathepsin molecule. In some embodiments, these cells generate an increased level of active fusogen, leading to a higher proportion of fusogenically active fusosomes.

Abstract: The present disclosure generally relates to a method for preparing a powder or granular foam control compositions and methods for reducing or preventing or breaking foam in various applications such as powder detergents as well as coatings, cementing, concrete, gypsum board and other construction type applications or in some agricultural formulations like fertilizers, herbicides and pesticides.

Abstract: Therapeutic chondrisome compositions and related methods are described.

Abstract: Therapeutic chondrisome and mitoplast compositions and related methods are described.

Abstract: In some aspects, fusosome compositions and methods are described herein that comprise membrane enclosed preparations, comprising a fusogen. In some embodiments, the fusosome can fuse to the target cell, thereby delivering complex biologic agents to the target cell cytoplasm.

Abstract: The present disclosure generally relates to a method for preparing a powder or granular foam control compositions and methods for reducing or preventing or breaking foam in various applications such as powder detergents as well as coatings, cementing, concrete, gypsum board and other construction type applications or in some agricultural formulations like fertilizers, herbicides and pesticides.

Abstract: Fusosome compositions and methods are described herein.

Abstract: The present disclosure provides, at least in part, methods and compositions for in vivo fusosome delivery. In some embodiments, the fusosome comprises a combination of elements that promote specificity for target cells, e.g., one or more of a fusogen, a positive target cell-specific regulatory element, and a non-target cell-specific regulatory element. In some embodiments, the fusosome comprises one or more modifications that decrease an immune response against the fusosome.

Abstract: In some aspects, fusosome compositions and methods are described herein that comprise membrane enclosed preparations, comprising a fusogen. In some embodiments, the fusosome can the target cell, thereby delivering complex biologic agents to the target cell cytoplasm.

Abstract: The present disclosure provides, at least in part, methods and compositions for in vivo fusosome delivery. In some embodiments, the fusosome comprises a combination of elements that promote specificity for target cells, e.g., one or more of a fusogen, a positive target cell-specific regulatory element, and a non-target cell-specific regulatory element. In some embodiments, the fusosome comprises one or more modifications that decrease an immune response against the fusosome.

Abstract: Methods and compositions for modulating a target genome are disclosed.

Abstract: Therapeutic chondrisome compositions and related methods are described.

Abstract: A method and system generate a building operational performance analysis output. A synthetic data set is generated and includes a set of 3D building conceptual mass geometries. The generating includes identifying geometry types, dividing the geometry types into categories, and algorithmically generating the mass geometries using a separate workflow for each category using generative design. Analytical models associated with each of the mass geometries are generated. Simulation results are generated for each of the analytical models. A surrogate model is trained based on a set of features extracted from the simulation results using machine learning (ML). The ML iteratively determines the set of features based on a measured accuracy of the surrogate model. Geometry input is received and processed through the surrogate model to generate the building operational performance analysis output which is then used to inform a designer of an approximate Energy Use Intensity of the geometry input.

Abstract: The present disclosure provides, at least in part, methods and compositions for in vivo fusosome delivery. In some embodiments, the fusosome comprises a combination of elements that promote specificity for target cells, e.g., one or more of a fusogen, a positive target cell-specific regulatory element, and a non-target cell-specific regulatory element. In some embodiments, the fusosome comprises one or more modifications that decrease an immune response against the fusosome.

Abstract: Provided herein are lipid particles containing a lipid bilayer enclosing a lumen or cavity, a henipavirus F protein molecule or biologically active portion thereof, and a targeted envelope protein containing a henipavirus envelope attachment glycoprotein G (G protein) or biologically active portion thereof and a binding domain, such as a single domain antibody (sdAb) variable domain. Also provided herein are targeted envelope proteins containing a G protein fused or linked to a binding domain, such as a sdAb variable domain, and polynucleotides encoding such proteins. Also provided are producer cells and compositions containing such targeted lipid particles and methods of making and using the targeted lipid particles.

Abstract: A method for rapidly filling a compressed gas storage tank with a moderated temperature rise using a Coanda nozzle to inject the feed gas into the tank and using the Coanda nozzle to direct the feed gas along the inner surface of the storage tank; entraining the stored gas with the feed gas that is flowing under the influence of the Coanda effect to flow along the inner surface of the gas storage tank; and transferring heat from the flowing gas to the external walls of the tank. Also, a compressed gas storage tank for rapid filling with a moderated temperature rise comprising: a gas storage tank and a Coanda nozzle capable of directing feed gas that is injected into the gas storage tank along the inner surface of the gas storage tank.

Abstract: The present disclosure provides, at least in part, methods and compositions for in vivo fusosome delivery. In some embodiments, the fusosome comprises a combination of elements that promote specificity for target cells, e.g., one or more of a re-targeted fusogen, a positive target cell-specific regulatory element, and a non-target cell-specific regulatory element. In some embodiments, the fusosome comprises one or more modifications that decrease an immune response against the fusosome.

Abstract: The present disclosure provides, at least in part, methods and compositions for in vivo fusosome delivery. In some embodiments, the fusosome comprises a combination of elements that promote specificity for target cells, e.g., one or more of a fusogen, a positive target cell-specific regulatory element, and a non-target cell-specific regulatory element. In some embodiments, the fusosome comprises one or more modifications that decrease an immune response against the fusosome.